Momoi, M., Hiraide, T., Shinya, Y., Momota, H., Fukui, S., Kawakami, M., . . . Kataoka, M. (2021). Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension. Ther Adv Respir Dis.
Chicago Style aipamenaMomoi, Mizuki, Takahiro Hiraide, Yoshiki Shinya, Hiromi Momota, Shogo Fukui, Michiyuki Kawakami, Yuji Itabashi, Keiichi Fukuda, and Masaharu Kataoka. "Triple Oral Combination Therapy With Macitentan, Riociguat, and Selexipag for Pulmonary Arterial Hypertension." Ther Adv Respir Dis 2021.
MLA aipamenaMomoi, Mizuki, et al. "Triple Oral Combination Therapy With Macitentan, Riociguat, and Selexipag for Pulmonary Arterial Hypertension." Ther Adv Respir Dis 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.